Surrendered on reissue Mar 19, 2019 · Low confidence
20-year base term ends Feb 2, 2027
Surrendered on reissue Mar 19, 2019 · its term and maintenance fees continue in US RE47,301.
Feb 2, 2007
Mar 19, 2019
Jul 21, 2015
Feb 2, 2027
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 2, 2007, when application 11/701,699, the earliest non-provisional in its chain, was filed (this one was filed Aug 19, 2013); a parent in its chain could not be resolved (the next row) | Feb 2, 2027 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,524,883) | resolves to Feb 2, 2027, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case" | no change | Low confidence |
| Reissue | US RE47,301 issued Mar 19, 2019, and this patent's term continues in it (35 U.S.C. 251, 252) | surrendered Mar 19, 2019 | High confidence |
| Surrendered on reissue | The steps above, in order | Mar 19, 2019 | Low confidence |
This family
| US 7,732,595 | In force no later than Jul 2027 | no later than Jul 2027 |
| US 7,671,192 | In force Apr 2027 | Apr 2027 |
| US 7,956,179 | In force Feb 2027 | Feb 2027 |
| US 8,106,183 | In force Feb 2027 | Feb 2027 |
| US 8,268,988 | In force Feb 2027 | Feb 2027 |
| US 8,524,883 | In force Feb 2027 | Feb 2027 |
| US 9,085,601 | this patent Mar 2019 | Mar 2019 |
| US RE47,301 | In force Feb 2027 | Feb 2027 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 31, 2013 Reel 31864, frame 586 | Gilead Palo Alto, Inc. | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| Apr 4, 2014 Reel 32610, frame 639 | Zablocki, Jeff; Elzein, Elfaith | CV Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 4, 2014 Reel 32610, frame 686 | Apex Merger Sub, Inc.; CV Therapeutics, Inc. | Gilead Palo Alto, Inc. | Merger |
| Apr 4, 2014 Reel 32610, frame 736 | Lemons, Travis; Seemayer, Robert | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 8,524,883, ends no earlier than this term, so it caps nothing.